Dr Herre:
Articles:
Yousef SE, Herre JM. Brugada syndrome mimicking acute coronary syndrome. South Med J. 98:817-21, 2005.
Grady KL, Naftel D, Pamboukian SV, Frazier OH, Hauptman P, Herre J, Eisen H, Smart F, Bourge R; Cardiac Transplant Research Database Group. Postoperative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of postoperative weight change. J Heart Lung Transplant: 24:1424-30, 2005.
Sharma A, Epstein AE, Herre JM, Klein RC, Platia EV, Wilkoff B, Ledingham RB, Greene HL, Hallstrom AP; DAVID Investigators. A comparison of the AVID and DAVID trials of implantable defibrillators. Am J Cardiol. 95:1431-35, 2005.
Abstracts:
Lietz K, Herre JM. Left ventricular systolic dysfunction is an independent predictor for cardiac death in heart transplant recipients. J Heart Lung Transplantation 24:542, 2005.
Leitz K, Herre JM. The risk of cardiac death in heart transplant recipients with and without angiographically detected coronary vasculopathy. J Heart Lung Transplantation 24:591, 2005.
Gold M, Hue-The Shih, Herre J, Schwartz M, Zhang Y, Breiter D. Mortality differences among patients with right and left sided defibrillator implants. Circulation, 112:II-373, 2005.
Lietz K, Herre JM, Miller LW. The natural history of cardiac allograft systolic function and deteminant of functional capacity in the U.S. population of heart transplant recipients. Circulation 112:II-544, 2005.
Dr Stine:
Abstract:
Tift Mann, Stephen G. Ellis, Mirle Kellett, Russell Raymond, Kevin Coy, Ronald A. Stine, A.R. Zaki Masud, John Douglas, Joerg Koglin, Gregg W. Stone. 9-month Results from the TAXUS V Trial, The TAXUS 2.25mm Paclitaxel-Eluting Stent in a Complex Patient Population. Presented at TCT (Transcatheter Cardiovascular Therapeutics) and ACC (American College of Cardiology) 2005 annual meetings.
Dr Rich:
Abstracts:
Rich JB, Speir A, Bladergroen B, Crosby I, The Virginia Cardiac Surgery Quality Initiative, “Making a Business Case for Quality with Information Sharing”. Presented at the Society of Thoracic Surgeons Advances in Quality and Outcomes Conference, Chicago, IL, September 30, 2005.
Rich JB, Speir A, Bladergroen B, Crosby I, The Virginia Cardiac Surgery Quality Initiative, “Models and Measures in Paying for Performance in Cardiac Surgery in Virginia”. Presented at the Society of Thoracic Surgeons Advances in Quality and Outcomes Conference, Chicago, IL, September 30, 2005.
Articles:
Rich JB: Quality Indicators, Performance Measures, and Accountability: The Right Thing, at the
Right Time, for the Right Reason. The Journal of Thoracic and Cardiovascular Surgery, January
2006.
Rich JB: Pay for Performance: Health Care Revived or Health Care Imbibed? The America HeartHospital Journal, Volume 4-number 1, Winter, 2006.
Dr Brush:
Articles:
Cardiovascular Quality Boot Camp at the American Heart Association's 6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke
ACC Cardiosource: Date Posted: 7/27/2005
Douglas PS, Brush JE. President's Page: Quality: it's in your hands. J Am Coll Cardiol. 2005 Jun 7;45(11):1903-4.
Brush JE, Radford MJ, Krumholz HM. Integrating Clinical Practice Guidelines Into the Routine of Everyday Practice. Critical Pathways in Cardiology. 4(3):161-167, September 2005.
Brush JE, Brough J, Valentine CM. A Cardiac Discharge Contract. Critical Pathways in Cardiology. 4(3):115-16, September 2005.
Krumholz HM, Brindis RG, Brush JE, Cohen DJ, Epstein AJ, Furie K, Howard G, Peterson ED, Rathore SS, Smith SC, Spertus JA, Wang Y, Norman ST. Standards for Statistical Models Used for Reporting of Public Outcomes: An American Heart Association Scientific Statement. Circulation (in press)
Brush, JE, Balakrishnan SA, Brough J, Hartman C, Hines G, Liverman DP, Parker JP, Rich J, Tindall N. Implementation of a Continuous Quality Improvement Program for Percutaneous Coronary Intervention and Cardiac Surgery at a Large community Hospital. Am Heart J (accepted for publication).
Spertus JA, Kettlekamp R, Vance C, Jones PG, Brush JE, Bach RG, Messenger JC, Krumholz HM, Cohen DJ. Incidence and Predictors of Discontinuation of Thienopyridine Therapy at 1-Month After Coronary Stenting in AMI (submitted for publication).
Kernis SJ, Cohen DJ, Reid KJ, Brush JE, Bach RG, Messenger JC, Rumsfeld JS, Khanal S, Curtis JP, Peterson E, Krumhopz HM, Spertus JA. Clinical Outcomes Associated with Use of Drug-Eluting Stents Compared with Bare-Metal Stents for Primary Percutaneous Interevention. (submitted for publication).